GOVERNANCE
Responsible Innovation
Innovation in advanced therapeutics must operate within clearly defined scientific, quality and ethical boundaries
Our governance framework prioritises:
SCIENTIFIC INTEGRITY
Data-driven decision-making and reproducible research
PRODUCT QUALITY
Defined manufacturing and analytical controls
PATIENT SAFETY
Risk-based development and appropriate clinical oversight
ETHICAL RESEARCH
Responsible biological sourcing and clinical investigation
DATA INTEGRITY
Accurate, attributable and traceable scientific records
REGULATORY RESPONSIBILITY
Development aligned with applicable national and international requirements
TRANSPARENCY
Clear differentiation between scientific research, investigational development and established clinical evidence